Clinical studyRandomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease∗∗: One-year results of the essence study☆,
Under an Elsevier user license
open archive
Abbreviations
CI
confidence interval
CK
creatine kinase
ECG
electrocardiographic
ESSENCE
Efficacy and Safety of Subcutaneous Enoxaparin in Non–Q wave Coronary Events
LMWH
low molecular weight heparin
MI
myocardial infarction
OR
odds ratio
PCI
percutaneous coronary intervention
UFH
unfractionated heparin
Cited by (0)
- ☆
This study was supported by the Rhone-Poulenc Rorer Corporation, Antony, France and Collegeville, Pennsylvania.
- ∗∗
A list of participating ESSENCE Study Group investigators may be found in N Engl J Med 1997;337:447–52.
Copyright © 2000 American College of Cardiology. Published by Elsevier Inc. All rights reserved.